Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Takahiro, Katsuda"'
Autor:
Hiroki Nasu, Shin Nishio, Jongmyung Park, Teruyuki Yoshimitsu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Kimio Ushijima
Publikováno v:
International Journal of Clinical Oncology. 27:790-801
Platinum-resistant ovarian cancer (PROC) is usually treated with single-agent chemotherapy. A synergistic effect of gemcitabine and platinum has been reported in PROC. We evaluated the efficacy and safety of gemcitabine and carboplatin with or withou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f925c7287333dca2178d7b1397cf50
https://doi.org/10.1007/s10147-021-02103-7
https://doi.org/10.1007/s10147-021-02103-7
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 36:120-126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afb8e2cf095a8c01ce7ccd8fbf761465
https://doi.org/10.5180/jsgoe.36.1_120
https://doi.org/10.5180/jsgoe.36.1_120
Autor:
Daisuke Miyahara, Nam Sung Ouk, Toyofumi Hirakawa, Chihiro Kiyoshima, Daisuke Izuchi, Kohei Miyata, Koichiro Shigekawa, Fusanori Yotsumoto, Ayako Sanui, Masamitsu Kurakazu, Ryota Araki, Masaharu Murata, Kyoko Shirota, Satoshi Fukagawa, Tomohiro Ito, Hiroko Ito, Shingo Miyamoto, Takahiro Katsuda, Masahide Kuroki, Daichi Urushiyama, Kenichi Yoshikawa, Shin'ichiro Yasunaga
Publikováno v:
Anticancer Research. 38:4347-4351
Background/aim Many anticancer agents including molecularly-targeted drugs have been developed for ovarian cancer. However, the prognosis of recurrent ovarian cancer remains extremely poor. Heparin-binding epidermal growth factor-like growth factor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d06a4583fadfa4ed224807f6263aef
https://doi.org/10.21873/anticanres.12735
https://doi.org/10.21873/anticanres.12735
Autor:
Masaharu Murata, Hiroshi Yagi, Kyoko Shirota, Satoshi Fukagawa, Shingo Miyamoto, Chihiro Kiyoshima, Kiyoko Kato, Haruchika Anan, Shin'ichiro Yasunaga, Kohei Miyata, Daisuke Miyahara, Sung Ouk Nam, Takahiro Katsuda, Fusanori Yotsumoto
Publikováno v:
Cancer Science
Ovarian cancer is the most lethal gynecologic malignancy. Recently, several molecularly targeted anticancer agents have been developed for ovarian cancer; however, its prognosis remains extremely poor. The development of molecularly targeted therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::976bd933d18cff4587acf7719778de37
https://doi.org/10.1111/cas.13210
https://doi.org/10.1111/cas.13210
Autor:
Daisuke Miyahara, Satoshi Fukagawa, Shin'ichiro Yasunaga, Takahiro Katsuda, Kohei Miyata, Sung Ouk Nam, Takashi Odawara, Fusanori Yotsumoto, Toyokazu Ishikawa, Shingo Miyamoto, Sadao Manabe
Publikováno v:
Anticancer Research. 37
Advanced lung cancer is one of the most lethal malignancies. Many anticancer agents have been developed for lung cancer with epidermal growth factor receptor (EGFR) mutations, but its prognosis remains extremely poor. The development of molecularly-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27cb430107c9e0576d349fe4f572cf5c
https://doi.org/10.21873/anticanres.11761
https://doi.org/10.21873/anticanres.11761
Autor:
Fusanori, Yotsumoto, Satoshi, Fukagawa, Kohei, Miyata, Sung Ouk, Nam, Takahiro, Katsuda, Daisuke, Miyahara, Takashi, Odawara, Sadao, Manabe, Toyokazu, Ishikawa, Shin'ichiro, Yasunaga, Shingo, Miyamoto
Publikováno v:
Anticancer research. 37(7)
Advanced lung cancer is one of the most lethal malignancies. Many anticancer agents have been developed for lung cancer with epidermal growth factor receptor (EGFR) mutations, but its prognosis remains extremely poor. The development of molecularly-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5ff202e320ef417ed2ebc3b4b9e9d33
https://pubmed.ncbi.nlm.nih.gov/28668882
https://pubmed.ncbi.nlm.nih.gov/28668882
Autor:
Akimasa Takahashi, Kazuyoshi Kato, Motoki Matsuura, Takahiro Katsuda, Maki Matoda, Hidetaka Nomura, Sanshiro Okamoto, Hiroyuki Kanao, Eiji Kondo, Kohei Omatsu, Kuniko Utsugi, Nobuhiro Takeshima
Publikováno v:
Medicine; 9/15/2017, Vol. 96 Issue 37, p1-6, 6p, 4 Charts, 2 Graphs
Publikováno v:
Gynecologic oncology. 140(3)
Objective Upper abdominal spreading of advanced-stage ovarian cancer often involves the diaphragm. In addition, bulky diaphragmatic tumors occasionally infiltrate the liver. Here, we describe our early experiences with a ventral liver mobilization te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb08d4c50555c7c5e037bd45f048c580
https://pubmed.ncbi.nlm.nih.gov/26801940
https://pubmed.ncbi.nlm.nih.gov/26801940
Autor:
Daisuke, Miyahara, Taeko, Ueda, Takahiro, Katsuda, Miyako, Maehara, Satoshi, Fukagawa, Kohei, Miyata, Sung Ouk, Nam, Haruhiko, Kondo, Shingo, Miyamoto
Publikováno v:
Anticancer research. 35(8)
The study was designed to evaluate the safety of combined chemotherapy with pegylated liposomal doxorubicin (PLD) and irinotecan (CPT-11) in patients with recurrent ovarian cancer.Six patients with platinum-resistant and taxane-pretreated ovarian can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cab1ad68814bbd7f32d13a876cbf7dd
https://pubmed.ncbi.nlm.nih.gov/26168496
https://pubmed.ncbi.nlm.nih.gov/26168496
Autor:
Miyako, Maehara, Taeko, Ueda, Daisuke, Miyahara, Yoko, Takahashi, Kohei, Miyata, Sung Ouk, Nam, Takahiro, Katsuda, Haruhiko, Kondo, Shingo, Miyamoto
Publikováno v:
Anticancer research. 35(8)
This study aimed to evaluate the efficacy of aprepitant, a neurokinin (NK)1 receptor antagonist, on chemotherapy-induced nausea and vomiting (CINV).A randomized, open-labeled, parallel-design study was undertaken in gynecologic-cancer (GC) patients a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6906233511df7633790e4345754b8bd
https://pubmed.ncbi.nlm.nih.gov/26168497
https://pubmed.ncbi.nlm.nih.gov/26168497